Praxis Precision Medicines (PRAX) Earnings Date & Reports
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
PRAX is expected to report earnings to rise 23.00% to -352 cents per share on November 11
Q3'26
Est.
$-3.53
Q2'26
Beat
by $0.80
Q1'26
Beat
by $0.40
Q4'25
Missed
by $0.41
Q3'25
Beat
by $0.11
The last earnings report on August 06 showed earnings per share of -286 cents, beating the estimate of -367 cents. With 121.08K shares outstanding, the current market capitalization sits at 7.84B.